Conference Programme

The Reception   18:30 - 21:00 Wednesday 23rd May

The Conference  08:15 - 18:30 Thursday 24th May

Biotech Investment Room

8.15 – 9.00       Registration

9.00 – 9.05       Welcome From the Conference Founder
Mattias Johansson, Director, Ezenze Ltd

9.05 – 9.30       Keynote from Dr Søren Bregenholt, Corporate Vice President, Global Research Strategy and Operations, Novo Nordisk

9.30 – 10.15      What's on the hotplate and what's simmering at the surface
(Panel discussion on Investment trends)

10.15 – 10.45    Reproductive Medicine & Women’s Health: A key area for Ferring Pharmaceuticals
Dr Henk Jan Out, VP Reproductive Medicine & Women’s Health, Global Clinical Research & Development.
Ferring Pharmaceuticals

10.45 – 11.00    Coffee

11:00 – 12:30    Company Presentations
Biotech Investment Room and Technology Room

12.30 – 13.30    NETWORKING LUNCH

13.30 – 14.15    Technologies and Treatments for Women's Health (Panel Discussion)

14.15 – 15.30    Company Presentations
Biotech Investment Room and Technology Room

15:30 – 15.45    Coffee

15.45 – 16:30    A Day in the Life of a Nordic CEO - is it different for UK CEOs?
(Panel Session)

16.30 – 17:15    If I knew then what I know today (Panel Discussion)
Chaired by Mike Ward, Scrip Pharma Intelligence
Panellists: Anker Lundemose, Mission Therapeutics; David Colpman,Forendo Pharma,HRA Pharma,Orexo AB; Annalisa Jenkins, PlaqueTec.

17.15 – 17.30    Conclusions and Q & A
Hakan Goker, M Ventures and Mary Clark, Optimum Strategic Communications

17.30 – 18.30    Afternoon Drinks Reception
Hosted by Mattias Johansson, Director, Ezenze Ltd

1:1 meetings take place throughout the day and are pre-booked online.
Partnering opens 19th April.

Investors that registered to attend the Anglonordic Life Science Conference in 2017:
4BIO Capital Partners, Advent Life Sciences, Albion Ventures, Angel investor, Animalcare, Arcus Altor, Arix Bioscience, Belsize Asset Management, BioCity Group, BioSeed Capital, Caldwell Capital, Cambridge Innovation Capital, Capricorn Venture Partners, CBC Investment Group, Certus, Clubb Capital, Deepbridge Capital, Epidarex Capital, Esperante, European Investment Fund, Fort Rock Capital, GHO Capital, Harbert European Growth Capital, Health Enterprise East, IAG, Ignite Capital Partners, Industrifonden, Inventages, IP Group, IPF Partners, Johnson & Johnson Innovation, Lilly, Locate in Limburg, LSP, Medicon SD, M Ventures, Metellus AG, Molecular Warehouse, MVM Life Science Partners, NeoMed, NetScientific, New Science Global Healthcare Fund, Newstock Capital, NIHR Office for Clinical Research Infrastructure, Norgine Ventures Management, O2h Ventures, Octopus Ventures, Pfizer, Pharmalink AB, Rainbow Seed Fund, Rosetta Capital, Royal Bank of Canada (RBC), Ruffena Capital, SBA, Seventure, Spencer Stuart, SR One, Stifel, Sunstone Life Science Ventures, Tassi@Co, Teijin Pharma, Ventac Partners, Wellcome Trust, Wren Capital.